Circle and OpenMind are developing USDC micropayment standards to enable autonomous machine-to-machine transactions for modern AI systems.]]>Circle and OpenMind are developing USDC micropayment standards to enable autonomous machine-to-machine transactions for modern AI systems.]]>

Circle and OpenMind Team Up to Build USDC Machine Payment Tech

For feedback or concerns regarding this content, please contact us at [email protected]
  • Circle and OpenMind are building USDC-powered micropayment standards to support autonomous machine-to-machine transactions across AI systems and digital infrastructure.
  • The collaboration introduces x402-based protocols enabling AI agents, APIs, and devices to perform automatic USDC payments in real time.

Circle’s decision to partner with OpenMind marks a new step for the company in building a USDC-based machine-to-machine payment standard. Its primary focus is on delivering a micropayment protocol that allows AI agents, applications, and even physical devices to conduct automated transactions without human intervention.

How Circle Plans to Push Micropayments Into an AI-Driven Future

The core of this plan lies in the development of a USDC-based micropayment protocol that can be adopted by AI agents, applications, and even physical devices. Circle states that this technology will utilize the x402 payment standard, which allows HTTP requests to simultaneously contain payment processing, enabling small transactions to be automated without human involvement.

OpenMind, on the other hand, is acting as a partner, helping build the technical foundation for the smooth operation of this entire system. If implemented correctly, this model could become the foundation for a self-driving machine economy. This direction also gives data vendors, compute platforms, and API marketplaces a fresh way to earn, especially those that have long depended on older payment setups.

However, while the plan looks promising, the real-world implementation of these machine-to-machine payments is still in its infancy. The x402 technology needs support from data providers, cloud providers, and APIs willing to accept micropayments.

Furthermore, this development direction is consistent with our report last week, where we highlighted Circle’s move to bring native USDC and CCTP to the Monad network. At that time, Circle strengthened wallet and smart contract support so developers could build applications powered directly by USDC.

As cross-chain connectivity becomes more robust, it makes sense for Circle to expand its focus beyond stablecoin utilities to an automated payment system that fuels the next generation of digital services.

We also highlighted Circle’s partnership last August with Finastra, which integrated USDC settlement into the Global PAYplus platform. Many global banks are leveraging this integration to accelerate cross-border transactions with more efficient processes and maintain regulatory compliance. Banks also gain a fast settlement option without the need to build new infrastructure, something that has been quite challenging in the past.

]]>
Market Opportunity
USDCoin Logo
USDCoin Price(USDC)
$1.0001
$1.0001$1.0001
+0.02%
USD
USDCoin (USDC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09